" class="no-js "lang="en-US"> Oncology Archives - Medtech Alert
Friday, April 12, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

ENSEM Announces the Promotion of Shengfang Jin, PhD to President & Chief Executive Officer

Ensem Therapeutics, a biotechnology company focusing on high-value and difficult-to-drug oncology targets, today announced the […]

CANbridge Announces Full Enrollment Reached in China Region of the Global LIVMARLI® (CAN108) EMBARK Phase 2 Study in Biliary Atresia

CANbridge Pharmaceuticals, a leading China-based global biopharmaceutical company committed to the research, development and commercialization […]

Juha Punnonen, M.D., Ph.D. Joins Hinge Bio as Chief Development Officer

Hinge Bio, a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined […]

Biological Dynamics Case Report Published in "Frontiers in Oncology" Demonstrates Advancement in the Detection of Early-Stage Pancreatic Lesions

Biological Dynamics, a life sciences company focused on developing and commercializing exosome isolation technology for […]

Discovery Life Sciences Joins Akoya Biosciences' Global Service Provider Network to Accelerate Immuno-oncology Research

Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, have announced that it has officially […]

Sony and Astellas Enter into Collaborative Research Agreement to Discover a Novel ADC Platform for the Oncology Field

Sony Corporation and Astellas Pharma today announced that they have entered into a collaborative research […]

Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology

Bayer and Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics […]

Genmab and argenx Enter Partnership to Advance Antibody Therapies in Immunology and Oncology

Genmab and argenx announced today that they have entered into a collaboration agreement to jointly […]

M2GEN Rebrands to Aster Insights

M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomic data to accelerate medical […]

TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics

TORL BioTherapeutics, a biopharmaceutical company focused on developing new biologics for cancer treatment, has announced […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more